Clinical Trials Insight: 700024236
Phase of Trial: Phase II
Latest Information Update: 28 Nov 2007
At a glance
- Drugs Arimoclomol (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- Sponsors CytRx Corporation
- 28 Nov 2007 Results have been reported by CytRx Corporation.
- 28 Nov 2007 Status changed from in progress to completed.
- 29 Jun 2007 New trial record.